Investors – Valneva

Our growing commercial business is funding Valneva’s exciting R&D pipeline

Stock Information

€2,80 -1,23% Last update: October 18, 2019 at 17:35 CET Stock Price

“We have the only clinical-stage vaccine program against Lyme disease worldwide.”

Valneva held its R&D Investor Day on July 9, 2019 in New York.

October 21, 2019

October 27, 2019

Campus Bio-Ouest
6, Rue Alain Bombard
44800 Saint-Herblain, France

T: +33 2 28 07 37 10 investors@valneva.com

Submit

September 30, 2019

September 19, 2019

August 19, 2019